Table 1.
Cytokine levels in COVID19 patients by status.
|
*Cytokine pg/ml |
Survival |
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alive, N = 59 |
Dead, N = 12 |
||||||||||||||
| Mean | SD | Min | 25% | Median | 75% | Max | Mean | SD | Min | 25% | Median | 75% | Max | p | |
| IL1β | 0.67 | 1.38 | 0.05 | 0.17 | 0.31 | 0.67 | 10.15 | 0.64 | 0.77 | 0.25 | 0.27 | 0.41 | 0.58 | 3.01 | 0.9491 |
| IL6 | 117.24 | 229.48 | 0.44 | 17.81 | 39.65 | 99.77 | 1206.61 | 605.69 | 710.99 | 43.33 | 87.36 | 163.40 | 1222.01 | 1829.97 | <0.0001 |
| IL8 | 51.62 | 59.27 | 5.49 | 18.06 | 29.68 | 56.52 | 290.51 | 102.04 | 117.90 | 26.63 | 33.16 | 52.44 | 119.69 | 435.32 | 0.1739 |
| TNFα | 22.88 | 12.15 | 5.46 | 14.74 | 19.09 | 28.10 | 62.80 | 36.00 | 17.33 | 10.65 | 22.36 | 33.91 | 50.13 | 66.06 | 0.0023 |
*
Cytokine levels in healthy controls (mean + SD, median) were as follows: IL1β (0.10 ± 0.15, 0.03); IL6 (1.80+±0.88, 1.61); IL8 (13.09 ± 5.89, 10.04); TNFα (9.92 ± 2.04; 9.65).